Generic name: LOTEPREDNOL ETABONATE 2.5mg in 1mL
Dosage form: ophthalmic suspension
Medically reviewed by Drugs.com. Last updated on Nov 18, 2020.
Instill one to two drops of EYSUVIS into each eye four times daily for up to two weeks. This product should only be renewed after examination under magnification such as a slit lamp and evaluation of the intraocular pressure. [see Warnings and Precautions (5.1) and (5.2)].
Instruct patient to wash hands well before each use. Shake for two to three seconds before using.
If the patient is using other eye drops in addition to EYSUVIS, advise the patient to wait at least 5 minutes between instillation of EYSUVIS and other eye drops.
If a dose is missed, take the missed dose when remembered.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Eysuvis (loteprednol ophthalmic)
- Side Effects
- During Pregnancy or Breastfeeding
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: ophthalmic steroids
- FDA Approval History